Advanced Filters
noise

metabolic-syndrome Clinical Trials

A listing of metabolic-syndrome medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 149 clinical trials
K Kristi M. Crowe-White, PhD, RD

Spices for Cultivating a Healthy Gut Microbiome and Cardiometabolic Profile

Among food products receiving attention for their prebiotic functionality, spices represent a flavorful vehicle for cultivating a healthy gut microbiota. As the required doses of spice-derived polyphenols to elicit prebiotic and systemic metabolic effects are not well-characterized, additional research is warranted. Thus, we propose to use a food-first synbiotic (prebiotic …

50 - 69 years of age Female Phase N/A
J Jonathan Sinclair, DSc, PhD

Effects of Quercetin on Cardiometabolic Outcomes

Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated …

18 - 65 years of age All Phase N/A
K Karina G Pérez-Rubio, PhD

Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

The Metabolic Syndrome (MS) is a cluster of cardiometabolic risk factors, which include abdominal obesity, hyperglycemia, dyslipidemia, and high blood pressure. MS is a global health problem, it represents a risk factor for the progression of cardiovascular disease, which constitute the main cause of mortality in the world and in …

30 - 60 years of age All Phase 2
M Marie-Pierre St-Onge, PhD

Impact of Yo-Yo Sleep on Cardiometabolic Health

The goal of this clinical trial is to test the impact of repeated intermittent short sleep, with short sleep maintained 5 days per week followed by 2 days of prolonged sleep, compared to daily adequate sleep, on energy balance and cardiometabolic risk. A secondary goal of this research is to …

18 - 49 years of age All Phase N/A

Effects of Cetoleic Acid on Atherosclerosis (Ketolinsyre's Effekt på Aterosklerose)

In this Randomized Controlled Trial (RCT) we want to study the effect of an oil with high concentrations of cetoelic acid (C22:n1-11) (intervention) compared to supplements with a low concentration of cetoleic acid (control), but with equivalent content of EPA og DHA, on plasma levels of epa and dha as …

20 - 70 years of age All Phase N/A
J Jacek Kubica, prof.

Efficacy of Double vs Standard Empapagliflozin Dose for METabolic syndromE tReatment

The DEMETER - SIRIO 11 study is a phase III, multicenter, randomized, open-labled, investigator-initiated clinical trial with a 6 month follow-up. The study population will include 200 subjects with diagnosis of metabolic syndrome. All enrolled patients (nn=200) will be randomly assigned in 1:1 ratio to one of the two study …

18 - 85 years of age All Phase 3
E Eugene Barrett, MD, PhD

Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome

The primary objective of this study is to examine whether exercise training alone, liraglutide treatment alone or exercise training plus liraglutide treatment increases cardiac and skeletal muscle microvascular blood volume, improves vascular function of the conduit vessels, and enhances insulin's metabolic action in humans with Metabolic Syndrome. Subjects will be …

21 - 60 years of age All Phase 4
h hagar El-Hadidy, lecturer

Is There Effect of Adding Honey Intake to Free Walking in Metabolic Syndrome Children

Metabolic Syndrome is common in Children and complementary therapies are important in its treatment such exercise and functional food intake including honey.

9 - 12 years of age All Phase N/A
K Kuat P Oshakbayev, professor

Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome

Background. The prevalence of type 2 diabetes mellitus (T2D) in the world is constantly increasing. Treatment of T2D is complicated by arterial hypertension and obesity (metabolic syndrome - MS). Cardiovascular complications are the main cause of death in patients with MS. Objective weight loss improves clinical and laboratory parameters in …

35 - 65 years of age All Phase N/A
V Vivian Wang, Master

Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)

This study is a randomized, parallel-group, observer-masked clinical trial. A total of 120 obese participants with MetS will be enrolled. Eligible subjects will be randomly assigned to the ILI group or ULI group with an allocation ratio of 2:1. The ILI group will be instructed to eat in 8 hours …

20 - 65 years of age All Phase N/A

Simplify language using AI